Cardiac Amyloidosis

Marinos C. Dalakas, M. A. Gertz, L. J. Olson, W. D. Edwards, C. Y. li, P. A. Pellikka, D. R. Holmes, A. J. Tajik, Robert A. Kyle

Research output: Contribution to journalLetterpeer-review


To the Editor: The effort by Olson et al. (Sept. 17 issue)1 to characterize deposits of cardiac amyloid is identical to our work on the characterization of amyloid deposits in muscle and nerve biopsy specimens from patients with amyloid polyneuropathy of the “sporadic” type234 (the nonfamilial, nonsecretory immunoglobulin-derived amyloid). The study is also relevant to ours because in amyloid polyneuropathy the heart is involved by amyloid. I have concerns, however, about the specificity of the staining with the antiserums used. After 10 years of experience with the immunohistochemistry of amyloid, we have found that immunostaining is not as simple as.

Original languageEnglish (US)
Pages (from-to)641-642
Number of pages2
JournalNew England Journal of Medicine
Issue number10
StatePublished - Mar 10 1988

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Cardiac Amyloidosis'. Together they form a unique fingerprint.

Cite this